neoadjuvant chemotherapy

Arsh Singh, MD
Jan 18, 2016 1:00 PM

In a 33 y/o caucasian woman with T2N0 Her 2 Positive invasive ductal carcinoma (both by IHC and FISH), ER 50% and PR negative, is it okay to use AC followed by T along with herceptin and pertuzumab  in the neoadjuvant setting?